Table I.

Primers used in the present study.

Gene	Sequences
VEGF (forward)	5′-GACAGATCACAGGTACAG-3′
VEGF (reverse)	5′-GAAGCAGGTGAGAGTAAG-3′
VEGFR2 (forward)	5′-GGGAGTCTGTGGCATCTGAAG-3′
VEGFR2 (reverse)	5′-AATCTGGGCTGTGCTACCG-3′
Bax (forward)	5′-AGCTGAGCGAGTGTCTCAAG-3′
Bax (reverse)	5′-TGTCCAGCCCATGATGGTTC-3
Bcl-2 (forward)	5′-AGACCGAAGTCCGCAGAACC-3′
Bcl-2 (reverse)	5′-GAGACCACACTGCCCTGTTG-3′
Caspase-3 (forward)	5′-AACTGGACTGTGGCATTGAG-3′
Caspase-3 (reverse)	5′-ACAAAGCGACTGGATGAACC-3′
GAPDH (forward)	5′-CACCCACTCCTCCACCTTTG-3′
GAPDH (reverse)	5′-CCACCACCCTGTTGCTGTAG-3′

VEGF, vascular endothelial growth factor; VEGFR2, VEGF receptor 2; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2 associated X protein; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.